10 tips cat friendly veterinary clinics
Here we take a look at 10 simple steps you can take to make feline patients feel at ease at your practice. Click here to find out more information.
Search
Our Partnering Culture
We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives. Find out more about our partnering culture.
Our Health and Safety initiative - BE SAFE
We strive to keep our employees in good health, supporting their well-being across all working environments. Learn about our BE SAFE initiative.
From Idea to Drug
Development of a new drug starts with the hunt for effective compounds and finishes with the approval of the drug. Click here to learn more.
Heart Diseases
Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.
Sustainable Development - Our Commitment
View Boehringer Ingelheim's sustainable development commitment here. Our goal is to engage with different communities to change lives for the better.
Press Releases
Click here to find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news.
3 scopes for sustainability Saint Vulbas France
Click here to find out how Boehringer Ingelheim is working to improve the sustainability and biodiversity of the research site at Saint-Vulbas in France.
NASH
Learn more about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting the Boehringer Ingelheim site.
Accountability, Agility, Intrapreneurship
At Boehringer Ingelheim we work together with accountability, agility, and intrapreneurship. Click here to read about what this means for us here.
Corporate Social Responsibility
Boehringer Ingelheim is driven by a purpose to positively impact the lives of communities in India. Click here to learn more about our work in this area.
Our History
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies. Click here to learn more information about our history.
Featured Stories
Click here to see Boehringer Ingelheim's latest featured stories to help provide inspiration for both human and animal health and well-being.
More Health: For People & Animals
Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities.
Data Privacy
Boehringer Ingelheim International GmbH takes the protection of your personal data seriously. Click here to find out more about data privacy.
Animal Health
We care for animals, and are a global leader in the animal health industry. Click here to learn more about Boehringer Ingelheim's animal health work.
We are independent, family-owned
At Boehringer Ingelheim we are independent, family-owned and intend to remain so. Click here to discover how we live our Leitbild and learn more.
Imprint
Here you can access contact details and information about Boehringer Ingelheim International GmbH. Click here to find out and learn more information.
Terms of Use
Click here to read the terms of use on which you may make use of the website www.boehringer-ingelheim.com/in, whether as a visitor or a registered user.
Press Material
Find the latest press releases from Boehringer Ingelheim on animal health or access our media pool to view our corporate news. Click here to learn more.
The Core of our Leitbild
Click here to find out about the core of our leitbild. Here you can find out information about who we are and what we strive for at Boehringer Ingelheim.
Ethical Business Practices
Suppliers shall conduct their business in an ethical manner and act with integrity. Click here to read the supplier code of conduct and learn more.
Our Expectations
We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. Click here to learn more.
1988-2015
Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.